LiveGMP
LiveGMP
The Grey Market Premium for this IPO is currently showing steady interest.
Cautious approach recommended for retail investors.
Details about Gaudium IVF & Women Health are not yet available.
Investors looking at the Gaudium IVF & Women Health IPO are closely monitoring the Grey Market Premium (GMP) to gauge potential listing gains. Being a Mainboard IPO, Gaudium IVF & Women Health has attracted significant attention from both retail and institutional investors.
On this page, we provide real-time updates for Gaudium IVF & Women Health GMP, live subscription status, and day-wise premium history. Our goal is to help you decide whether to apply for Gaudium IVF & Women Health IPO based on fundamentals, market sentiment, and AI-powered analysis.
Track how many times Gaudium IVF & Women Health is subscribed across Retail, HNI, and QIB categories. High subscription often leads to higher GMP and listing gains.
Based on the current GMP of Gaudium IVF & Women Health, calculate your potential profit per lot. Remember, GMP is indicative and the actual listing price may vary.
Always check the RHP (Red Herring Prospectus) of Gaudium IVF & Women Health on the SEBI website for officially audited financials and risk factors before investing.
How to check Gaudium IVF & Women Health IPO Allotment Status?
You can check the allotment status for Gaudium IVF & Women Health on our Allotment Page once the registrar finalizes the basis of allotment.
What is the lot size for Gaudium IVF & Women Health?
The lot size and price band for Gaudium IVF & Women Health are available in the overview table above. Typically, one lot for a Mainboard IPO costs between ₹14,000 to ₹15,000 for retail investors.